Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanno M Witte

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cancer Research and Clinical Oncology|March 4, 2021
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluationNadine Hertel, Hartmut Merz, Heinz-Wolfram Bernd, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2021
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategiesNiklas Gebauer, Britta Mengler, Svenja Kopelke, et al.
Cancers|March 6, 2021
Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> RearrangementsVito Olschewski, Hanno M Witte, Veronica Bernard, et al.
Cancers|April 15, 2020
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell TransplantationHanno M Witte, Bastian Bonorden, Armin Riecke, et al.
Blood Advances|October 29, 2021
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathwaysHanno M Witte, Axel Künstner, Nadine Hertel, et al.
Frontiers in Immunology|October 30, 2020
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)Daniel Gagiannis, Julie Steinestel, Carsten Hackenbroch, et al.
British Journal of Haematology|September 18, 2020
Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphomaJohannes Rieken, Veronica Bernard, Hanno M Witte, et al.
Blood Advances|September 9, 2021
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphomaNiklas Gebauer, Hanno M Witte, Hartmut Merz, et al.
Frontiers in Oncology|March 16, 2023
Primary refractory plasmablastic lymphoma: A precision oncology approachHanno M Witte, Anke Fähnrich, Axel Künstner, et al.
Targeted Oncology|July 24, 2023
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)Hanno M Witte, Jörg Riedl, Axel Künstner, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cancer Research and Clinical Oncology|March 4, 2021
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluationNadine Hertel, Hartmut Merz, Heinz-Wolfram Bernd, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2021
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategiesNiklas Gebauer, Britta Mengler, Svenja Kopelke, et al.
Cancers|March 6, 2021
Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> RearrangementsVito Olschewski, Hanno M Witte, Veronica Bernard, et al.
Cancers|April 15, 2020
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell TransplantationHanno M Witte, Bastian Bonorden, Armin Riecke, et al.
Blood Advances|October 29, 2021
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathwaysHanno M Witte, Axel Künstner, Nadine Hertel, et al.
Frontiers in Immunology|October 30, 2020
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)Daniel Gagiannis, Julie Steinestel, Carsten Hackenbroch, et al.
British Journal of Haematology|September 18, 2020
Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphomaJohannes Rieken, Veronica Bernard, Hanno M Witte, et al.
Blood Advances|September 9, 2021
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphomaNiklas Gebauer, Hanno M Witte, Hartmut Merz, et al.
Frontiers in Oncology|March 16, 2023
Primary refractory plasmablastic lymphoma: A precision oncology approachHanno M Witte, Anke Fähnrich, Axel Künstner, et al.
Targeted Oncology|July 24, 2023
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)Hanno M Witte, Jörg Riedl, Axel Künstner, et al.
Pageof 3